Gulf International Bank (UK)’s Sarepta Therapeutics SRPT Stock Holding History

Gulf International Bank (UK)’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,800	Closed	-$140K	–	787
2021 Q2	$140K	Sell	3,800 -14,175	-79%	-$1.07M	﹤0.01%	730
2021 Q1	$1.34M	Sell	17,975 -300	-2%	-$27.7K	0.02%	605
2020 Q4	$3.12M	Sell	18,275 -2,500	-12%	-$370K	0.04%	441
2020 Q3	$2.92M	Sell	20,775 -175	-0.8%	-$26.6K	0.04%	402
2020 Q2	$3.36M	Hold	20,950	–	–	0.05%	344
2020 Q1	$2.05M	Hold	20,950	–	–	0.04%	416
2019 Q4	$2.7M	Hold	20,950	–	–	0.04%	434
2019 Q3	$1.58M	Buy	+20,950	New	+$2.47M	0.03%	532

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gulf International Bank (UK)'s SRPT Position: Q3 2021 in Review

Gulf International Bank (UK) sold out of Sarepta Therapeutics (SRPT) in Q3 2021, closing a stake of 3,800 shares — an estimated $140K sold.

Gulf International Bank (UK) first reported a position in SRPT in Q3 2019 and held it in 8 quarters. The position peaked at $3.36M in Q2 2020. 307 funds tracked by Wall St. Rank hold SRPT as of Q3 2021.

Gulf International Bank (UK) reported no remaining Sarepta Therapeutics position as of Q3 2021 after selling out during the quarter.
Gulf International Bank (UK) sold 3,800 Sarepta Therapeutics shares in Q3 2021, an estimated $140K.
Gulf International Bank (UK) first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 8 quarters.
Gulf International Bank (UK)'s Sarepta Therapeutics position peaked at $3.36M in Q2 2020.
307 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2021.

Based on Gulf International Bank (UK)'s 13F filing for Q3 2021, filed 10 Nov 2021.